(Philadelphia,
PA) - Rodney Camire, PhD, has been named Assistant
Professor of Pediatrics at the University of Pennsylvania
School of Medicine.
Dr. Camire graduated magna cum laude in 1994 with a
BA in Biochemistry from Saint Anselm College in New
Hampshire. Four years later, he earned a PhD in Biochemistry
from the University of Vermont. He completed his graduate
teaching fellowship and post-doctoral associate training
from the University of Vermont. From 1998 to 2001, he
completed his National Research Service Award post-doctoral
research training fellowships from both the University
of Pennsylvania and The Children's Hospital of Philadelphia
(CHOP).
Dr. Camire's current research interests focus on solving
problems related to blood coagulation including enzymology,
biochemistry, and molecular genetics of the enzyme.
He was awarded a 2001 Young Investigator Award from
the International Society on Thrombosis and Haemostasis
and the American Society of Hematology. He has three
patents pending on the understanding and treatments
of hemophilia based on his research at CHOP.
He is a member of several professional organizations
including the American Association for the Advancement
of Science, the American Society of Hematology and the
American Society of Biochemistry and Molecular Biology.
He was invited to lecture twice at the Annual Philadelphia
Workshop on Hemostasis, Thrombosis and Atherosclerosis
in 1998 and 1999. Dr. Camire has authored or co-authored
research papers in publications including Blood,
Journal of Biological Chemistry, and Biochemistry.
# # #
.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.